Section 4.2: Hepatitis B & Bloodborne Pathogen Protocols

Hepatitis B & Bloodborne Pathogen Protocols

Hemodialysis patients face a heightened risk of exposure to bloodborne pathogens, most notably Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus (HIV). Because treatments involve extracorporeal blood circuits, large-gauge needles, and frequent vascular access interventions, the potential for blood exposure is ever-present. Among these pathogens, Hepatitis B is particularly resilient and transmissible in the environment, prompting the CDC to mandate highly specific isolation protocols that every dialysis technologist must rigorously follow.

Hepatitis B: The Rationale for Strict Isolation

Hepatitis B is highly infectious; it can be transmitted through microscopic, invisible droplets of blood and can survive on environmental surfaces (such as machine panels, clamps, and chairs) for at least seven days. Unlike HCV and HIV, which require more direct blood-to-blood contact and degrade more quickly outside the body, HBV's environmental stability makes cross-contamination via shared equipment or staff hands a major vector for outbreaks in dialysis units.

To manage this risk, dialysis facilities monitor patients' HBV status using two primary blood tests:

1. Hepatitis B surface antigen (HBsAg): A positive result indicates that the patient currently has an active HBV infection and is infectious to others.
2. Hepatitis B surface antibody (anti-HBs): A positive result (usually >10 mIU/mL) indicates that the patient has immunity to HBV, either from prior resolved infection or successful vaccination.

Protocols for HBsAg-Positive Patients

When a patient tests positive for HBsAg, the facility must immediately implement strict isolation protocols to protect susceptible patients and staff.

1. Dedicated Isolation Room: The CDC mandates that HBsAg-positive patients must be dialyzed in a separate isolation room. This room must have a door that closes and separate designated clean and dirty areas. The isolation room acts as a physical barrier to prevent the spread of the virus to the general treatment floor.

2. Dedicated Machine and Equipment: The dialysis machine used for an HBsAg-positive patient must be dedicated solely to that patient (or other HBsAg-positive patients). It cannot be used for HBV-susceptible patients. Additionally, all non-disposable equipment, such as blood pressure cuffs, stethoscopes, and tourniquets, must be dedicated exclusively to the isolation room and not shared with the general patient population.

3. Dedicated Staffing: Staff assignments are a critical component of HBV isolation. A technician or nurse assigned to care for an HBsAg-positive patient during a shift must NOT care for HBV-susceptible patients at the same time. While it is acceptable for the staff member to care for HBV-immune patients concurrently (those with positive anti-HBs), they are strictly prohibited from crossing over to care for susceptible patients due to the high risk of cross-contamination via contaminated hands or clothing.

Hepatitis C and HIV Management

While Hepatitis B requires physical isolation rooms, Hepatitis C (HCV) and HIV do not require the same level of environmental separation. However, they demand unwavering adherence to Standard Precautions.

For patients with HCV or HIV, the CDC states that they can be dialyzed in the general treatment area. Dedicated machines or isolation rooms are not required. The transmission of HCV and HIV in dialysis units is almost exclusively linked to breaks in standard infection control practices, particularly cross-contamination through shared medication vials, improper hand hygiene, or inadequate cleaning of shared environmental surfaces.

Therefore, the primary defense against HCV and HIV transmission is the strict execution of routine infection control measures:

• Meticulous Hand Hygiene: Changing gloves and washing hands between every patient contact and after touching any potentially contaminated surface.
• Safe Injection Practices: Never sharing multi-dose medication vials between patients if the vial has been brought into the treatment area. Medications should ideally be prepared in a centralized clean room.
• Thorough Environmental Cleaning: Adhering to the required contact times for EPA-registered disinfectants on the dialysis machine and station surfaces.

Vaccination and Routine Screening

Prevention is the ultimate goal. All susceptible dialysis patients and staff should be offered the Hepatitis B vaccine series. Following vaccination, patients are tested for anti-HBs to confirm immunity.

Routine serological screening is a cornerstone of dialysis infection control. Susceptible patients are typically tested monthly for HBsAg to catch any new infections immediately. Patients with confirmed immunity are tested less frequently (e.g., annually). Routine screening for HCV antibodies (anti-HCV) is also conducted, usually upon admission and semi-annually thereafter, to identify any seroconversions that would indicate a breakdown in facility infection control practices.

By understanding the distinct environmental behaviors of these bloodborne pathogens, the CHT can appreciate the critical "why" behind the stringent protocols they execute daily.

Isolation Requirements by Bloodborne Pathogen